News & Events

News

Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who, like us, believe noninvasive brain stimulation harnesses the brain's own healing power—neuroplasticity. Nexstim is helping patients—and their families—get back the life they feared they had lost.

11-14-2016

Cook Children’s Hospital in Texas acquires NBS System from Nexstim Plc

11-11-2016

Nexstim Plc issues shares in standby equity distribution agreement pursuant to the financing arrangement announced on 21 July 2016, 11 November 2016

11-09-2016

Conversion of the convertible bond entered into between Nexstim Plc and Bracknor to shares and issuance of shares pursuant to the financing arrangement announced on 21 July 2016, 9 November 2016 #2

11-09-2016

Conversion of the convertible bond entered into between Nexstim Plc and Bracknor to shares and issuance of shares pursuant to the financing arrangement announced on 21 July 2016, 9 November 2016

11-08-2016

The conversion of the convertible loan between Nexstim Plc and Bracknor, 8 November 2016

11-02-2016

Spinal cord injury treatment being developed using Nexstim Plc’s NBS technology

11-02-2016

Nexstim Plc issues shares in standby equity distribution agreement

11-01-2016

The conversion of the convertible loan between Nexstim Plc and Bracknor, 1 November 2016

10-31-2016

The conversion of the convertible loan between Nexstim Plc and Bracknor, 31 October 2016

10-24-2016

Conversion of the convertible bond entered into between Nexstim Plc and Bracknor to shares and issuance of shares pursuant to the financing arrangement announced on 21 July 2016, 24 October 201

10-20-2016

The conversion of the convertible loan between Nexstim Plc and Bracknor 20th October 2016

10-17-2016

The conversion of the convertible loan between Nexstim Plc and Bracknor, 17 October 2016